Chengda Pharmaceutical announced that the half-year revenue for 2024 was 0.164 billion yuan, a decrease of 1.55% year-on-year; the net income attributable to the company's shareholders was 25.1748 million yuan, a decrease of 14.23% year-on-year.
诚达药业：2024年上半年净利润同比下降14.23%
Chengda Pharmaceutical: The net income in the first half of 2024 decreased by 14.23% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated